INTRODUCTION
============

The linear chromosomes and plasmids of *Streptomyces* species are capped by terminal proteins (TPs) at the 5′ ends of the DNA ([@B1]). The TP provides protection against exonuclease attack on the DNA, and functions as a primer for DNA synthesis to patch the single-stranded gaps at the 3′ ends during replication ([@B2]).

Several *Streptomyces* TPs have been isolated or identified from genome sequences. Most of them (designated Tpg) are highly conserved in sequences and size (184--185 aa) ([@B3],[@B4]). On *Streptomyces* chromosomes, the *tpg* gene forms an operon with a *tap* gene, which encodes another protein essential for end-patching DNA synthesis ([@B5]). Bao and Cohen ([@B5]) showed that the Tap protein of *S. coelicolor* (Tap^Sco^) interacts with Tpg of *S. coelicolor* (Tpg^Sco^) and the single-stranded telomere DNA, and proposed that Tap^Sco^ recruits and positions Tpg^Sco^ at the telomere during its replication. In an *in vitro* system, Yang *et al*. ([@B6]) demonstrated that Tpg^Sco^ was specifically deoxynucleotidylated by dCMP (the first nucleotide of the *S. coelicolor* chromosome) at a Thr residue.

A monopartite nuclear localization signal (NLS) motif was predicted downstream of and adjacent to a helix-turn-helix DNA-binding domain at the N-terminus of Tpg^Sco^ and the identical Tpg of *S. lividans*, Tpg^Sli^ ([@B4]). As more Tpg homologs were identified, NLS motifs were also found in all of them except perhaps that of pSCL2 plasmid and the predicted pseudogene products ([Fig. 1](#F1){ref-type="fig"}A). All these NLS motifs contain the consensus K(K/R)X(K/R) sequence for the basic core of monopartite NLS ([@B7]). Initially, this discovery was regarded as fortuitous, because: (*i*) NLSs often overlap with a DNA-binding domain, and sometimes are used for DNA binding ([@B8],[@B9]); and (*ii*) a nuclear localization function of a TP would appear incongruous in streptomycetes that lack a nucleus. Figure 1.Potential NLS sequences in TPs of *Streptomyces*. (**A**) The archetypal Tpg family. The plasmid-encoded Tpgs are designated by the plasmid names, and the chromosome-encoded Tpgs are designated by three-letter abbreviations of the species (Sav, *S. avermitilis*; Sco, *S. coelicolor*; Sli, *S. lividans*; Sro, *S. rochei*; Ssc, *S. scabies*). For those Tpgs that are encoded by the same replicon, they are distinguished by their gene numbers. Sources of the sequences are: *S*. *coelicolor* chromosome ([@B4]), *S. lividans* chromosome ([@B3]), *S. avermitilis* chromosome and SAP1 plasmid ([@B38]), pSV2 plasmid (pSV2.82) in *S. violaceoruber* (GenBank accession number NC_004934), pSLV45 plasmid *S. lavendulae* ([@B39]), pFRL1 plasmid in *Streptomyces* sp. FR1([@B40]), *S. rochei* chromosome and pSLA2-L and pSLA2-M plasmids ([@B41]), SLP2 plasmid in *S. lividans* ([@B4]), *S. scabies* chromosome (<http://www.sanger.ac.uk/Projects/S_scabies/>), pSCL2 plasmid in *S. clavuligerus* (GenBank accession number AAQ93595), pNO33 plasmid in *S. albulus* (GenBank accession number YP_170689). The locations of the DNA-binding HTH domain and potential NLS sequences are depicted by the open and filled box, respectively, on the prototype Tpg^Sco^. The potential NLS in various Tpgs (except the putative pseudogene products) are shaded in yellow. Within this region, the basic aa\'s are in red and Pro in blue. The length (in aa) of the Tpg proteins is indicated at the right. Conceptually translated products of proven pseudogenes (Tpg^SLP2.39^; Yang, C.-C., unpublished results) or putative pseudogenes (widely divergent sequence and/or anomalous length) are placed below the dashed line. (**B**) Tpc of SCP1 plasmid. The labels are as in (A).

Recently, a novel TP (designated Tpc) encoded by linear plasmid SCP1 of *S. coelicolor* was isolated and characterized ([@B10]). Tpc is distinct from Tpgs in both aa sequence and size (259 versus 184--185 aa), and represents the product of convergent evolution. Tpc also contains a predicted NLS ([Fig. 1](#F1){ref-type="fig"}B), which, however, differs from that on Tpg^Sco^ and Tpg^Sli^ in being separate from the DNA-binding domain, and in being bipartite. The finding of two distinct types of NLSs in two different types of TP suggested that their occurrences were not coincidental, and that they serve a real biological function.

In this study, we showed that the NLSs on both types of TP (Tpgs and Tpc) are functional in nuclear targeting. When fused to a triple green fluorescence protein concatemer (EGFP3), they could target the fusion protein into human nuclei. These TPs could also carry covalently attached DNA into the nuclei. TPs with a mutation in NLS are defective in nuclear localization, but remain competent in supporting end-patching and capping of linear replicons. This suggests that the nuclear targeting function of TPs has evolved independently of the end-patching function. All these findings indicate that the nuclear targeting of the TP-capped linear replicons of *Streptomyces* is biologically significant, and may mediate inter-kingdom gene transfer in soil.

MATERIALS AND METHODS
=====================

Growth and genetic manipulations of bacterial cultures and plasmids
-------------------------------------------------------------------

Bacterial cultures and plasmids are listed in [Table 1](#T1){ref-type="table"}. Basic microbiological and molecular biological procedures were according to Kieser *et al*. ([@B11]) and Sambrook *et al*. ([@B12]). *S. lividans* TK64 ([@B13]) and MR04 ([@B14]) was used for propagation of *Streptomyces* plasmids. Mutations in cloned genes were generated by site-directed mutagenesis by PCR. Table 1.Bacterial cultures and plasmids used in this studyStrain/plasmidRelevant genotype/descriptionSource/reference*S. lividans* TK64*pro-2 str-6* SLP2^−^ SLP3^−^([@B13])*S. lividans* MR04*pro-2 str-6 rec-46* Δ*dndA* Δ(*tap^Sli^-tpg^Sli^*) SLP2^−^ SLP3^−^([@B14])pEGFP3Plasmid containing a reporter gene EGFP3 (encoding triple EGFP protein concatemer) under the control of the CMV immediate-early promoter P~CMVIE~([@B15])pEGFP3-Tpg^Sco^pEGFP3 containing *tpg^Sco^* fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3-Tpg^Sco^ΔNLS5CpEGFP3 containing *tpg^Sco^* with a deletion of KRPRP fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3- Tpg^Sco^ΔNLS10CpEGFP3 containing *tpg^Sco^* with a deletion of EIKRPRPDLA fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3-NLS5CpEGFP3 containing KRPRP fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3-NLS10CpEGFP3 containing EIKRPRPDLA (from Tpg^Sco^) fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3-NLS10C(E1A)pEGFP3 containing AIKRPRPDLA fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}B; this studypEGFP3-NLS10C(I2A)pEGFP3 containing EAKRPRPDLA fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}B; this studypEGFP3-NLS10C(K3A)pEGFP3 containing EIARPRPDLA fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}B; this studypEGFP3-NLS10C(R4A)pEGFP3 containing EIKAPRPDLA fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}B; this studypEGFP3-NLS10C(R6A)pEGFP3 containing EIKRPAPDLA fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}B; this studypEGFP3-Tpg^Sav^pEGFP3 containing *tpg^Sav^* fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3-NLS10ApEGFP3 containing QIKKPRPDLA (from Tpg^Sav^) fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3-NLS10RpEGFP3 containing KLKRPRQDLR (from Tpg^pSLA2-M^/Tpg^pSLA2-L^) fused to the N-terminus of EGFP3[Fig. 2](#F2){ref-type="fig"}A; this studypEGFP3-TpcpEGFP3 containing Tpc fused to the N-terminus of EGFP3[Fig. 3](#F3){ref-type="fig"}; this studypEGFP3-NLS27SpEGFP3 containing the 27-aa NLS (from Tpc) fused to the N-terminus of EGFP3[Fig. 3](#F3){ref-type="fig"}; this studypEGFP3-TpcΔ(ARVRRR)pEGFP3 containing TpcΔ(ARVRRR) fused to the N-terminus of EGFP3[Fig. 3](#F3){ref-type="fig"}; this studypEGFP3-TpcΔ(RRRKKWT)pEGFP3 containing TpcΔ(RRRKKWT) fused to the N-terminus of EGFP3[Fig. 3](#F3){ref-type="fig"}; this studyPLUS986Llinear plasmid containing the *tap^Sco^-tpg^Sco^* operon, pSLA2 ARS and a pair of *S. lividans* chromosomal telomeres[Fig. 4](#F4){ref-type="fig"}A; this studypLUS986(K3A)pLUS986 with the K3A mutation in the NLS of Tpg^Sco^[Fig. 4](#F4){ref-type="fig"}; this studypLUS986(K3A)Llinear version of pLUS986(K3A)[Fig. 4](#F4){ref-type="fig"}; this studypLUS986(K3A)-EGFP3pLUS986(K3A) containing EGFP3 under the control of the CMV immediate-early promoter P~CMVIE~This studypLUS986(K3A)-EGFP3Llinear version of pLUS986(K3A)-EGFP3This studypLUS986(R4A)pLUS986 with the R4A mutation in the NLS of Tpg^Sco^[Fig. 4](#F4){ref-type="fig"}; this studypLUS986(R4A)Llinear version of pLUS986(R4A)[Fig. 4](#F4){ref-type="fig"}; this studypLUS892plasmid containing the *tac-tpc* region of SCP1, pSLA2 ARS of and a pair of SCP1 telomeres([@B10])pLUS892Llinear version of pLUS892[Fig. 4](#F4){ref-type="fig"}A; ([@B10])pLUS892(ΔARVRRR)pLUS892 containing the (ΔARVRRR) mutation in *tpc*[Fig. 4](#F4){ref-type="fig"}; this studypLUS892(ΔARVRRR)Llinear version of pLUS892(ΔARVRRR)[Fig. 4](#F4){ref-type="fig"}; this studypLUS966recombinant circular plasmid containing the terminal 372 bp of the *S. lividans* chromosome, the *tsr* (thiostrepton resistance) gene and a 6.4 kb autonomously replicating sequence of pSLA2([@B4])pLUS966-EGFP3pLUS966 with pEGFP3 sequence inserted at the *Hin*dIII site[Fig. 5](#F5){ref-type="fig"}A; This studypLUS966-EGFP3Llinear version of pLUS966-EGFP3[Fig. 5](#F5){ref-type="fig"}B; This study

Construction of EGFP3 fusion proteins
-------------------------------------

Tpg and Tpc genes and their NLS-deleted sequences were obtained by PCR, and oligonucleotides containing the NLS sequences were commercially synthesized. These sequences were inserted between the *Sac*I and *Eco*RI sites upstream of EGFP3 (encoding a triple green fluorescence protein concatemer under the control of the CMV immediate-early promoter) on pEGFP3 ([@B15]) to generate TP-EGFP3 and NLS-EGFP3 fusion proteins, respectively.

Construction of mini linear plasmids
------------------------------------

The 3.4 kb *Sac*I-*Hin*dIII fragment spanning the *tap^Sco^-tpg^Sco^* operon was generated by PCR, and inserted between the *Sac*I and *Hin*dIII sites of pLUS966 to generate pLUS986. The *tap^Sco^-tpg^Sco^* operon containing the K3A or R4A mutations was created by PCR using appropriate primer sets (listed in Supplementary Data), and used to replace the *tap^Sco^-tpg^Sco^* operon on pLUS986 to generate pLUS986(K3A) and pLUS986(R4A), respectively.

Mini linear plasmid pLUS892L containing the *tas* and *tpc* genes, the pSLA2 ARS, and a pair of SCP1 telomeres and its circular progenitor pLUS892 were described previously ([@B10]). The *tac*-*tpc* sequence containing the ΔARVRRR) mutation in *tpc* was created by PCR using appropriate primer sets (listed in Supplementary Data), and used to replace the corresponding *Hin*dIII fragment of pLUS892 to generate pLUS892 Δ(ARVRRR). *Hin*dIII-linearized pLUS966 and *Ase*I-linearized pEGFP3 were filled in by DNA polymerase I to create blunt ends, and ligated by T4 DNA ligase to create pLUS966-EGFP3.

Generation of linear plasmids from the circular progenitor plasmids followed the general procedure of Qin and Cohen ([@B16]). The circular plasmid DNA was linearized by *Ase*I in the ColE1 vector sequence and used to transform *S. lividans* TK64 or MR04. Linear plasmids were isolated from thiostrepton-resistant transformants, and confirmed by restriction analysis.

Transfection of human cell cultures
-----------------------------------

HeLa and HEK 293T human cell lines were grown in DMEM medium supplemented with 10% (vol/vol) fetal bovine serum. They were transfected using lipofectamine according to the procedure specified by the manufacturer (Invitrogen). Fluorescent transfected cells were scored under a fluorescence microscope. To prepare TP-capped linear plasmid DNA for transfection, *Streptomyces* cultures containing the plasmid were grown in YEME medium to exponential phase, harvested by centrifugation, treated with lysozyme (1 mg/ml) at 37° for 30 m, and osmotically lyzed by dilution in 10 vol of TE buffer. The lysate was electrophoresed in 0.8% agarose gel containing 0.05% SDS. Linear plasmid DNA was visualized by ethidium bromide staining and eluted electrophoretically.

NLS prediction
--------------

NLSs were predicted using the PredictNLS server (<http://cubic.bioc.columbia.edu/predictNLS>) based on Cokol *et al*. ([@B9]).

RESULTS
=======

Tpgs and their NLSs are functional in nuclear targeting
-------------------------------------------------------

To test the nuclear localization function, we fused the Tpg^Sco^ and Tpg^Sav^ sequences to the reporter gene EGFP3 (encoding a triple green fluorescence protein concatemer) under the control of the CMV immediate-early promoter (P~CMVIE~) on pEGFP3 ([@B15]) ([Fig. 1](#F1){ref-type="fig"}A), and introduced the constructed plasmids, pEGFP3-Tpg^Sco^ and pEGFP3-Tpg^Sav^, into HeLa and/or HEK 293T human cells by transfection using the lipofectamine procedure. Green fluorescence was produced in ∼80% of the transfected cells in 16 h after transfection, and the fluorescence accumulated in the nuclei of these cells ([Fig. 2](#F2){ref-type="fig"}A). In contrast, in cells transfected by the pEGFP3 vector, fluorescence was present mainly in the cytosol. These results indicated that the Tpg^Sco^ and Tpg^Sav^ sequences were functional in nuclear targeting. Figure 2.Nuclear localization function of Tpgs. (**A**) NLS in Tpgs. The vector used for transfection was pEGFP3. The Tpg sequences fused in-frame to the N-terminus of EGFP3 are listed to the left. The residues in Tpg^Sav^ and Tpg^pSLA2-L^/Tpg^pSLA2-M^ that differ from those in Tpg^Sco^ are underlined, and the mutant residue is in red. The nuclear localization test results ('−', negative; '+', positive) are shown in the fluorescent microscopic images of a representative transfected cell in the middle. The original source of the sequence and the plasmid construct are listed to the right. (**B**) 'Alanine Scan' mutant variants of Tpg^Sco^. The mutant decapeptides are listed to the left, and the introduced alanine is in red.

To test the role of the putative NLS of Tpg^Sco^ in nuclear localization, the predicted NLS motif (KRPRP) was fused to the N-terminus of EGFP3 ([Fig. 2](#F2){ref-type="fig"}A). HeLa cells transfected by the resulting plasmid, pEGFP3-NLS5C, displayed green fluorescence mainly in the cytosol. On the other hand, Tpg^Sco^ with a deletion of the pentapeptide lost its nuclear localization function when fused to EGFP3 (pEGFP3-Tpg^Sco^ΔNLS5C; [Fig. 2](#F2){ref-type="fig"}A). When an expanded NLS motif-containing decapeptide, EIKRPRPDLA, was fused to EGFP3 (pEGFP3-NLS10C), the fused protein was concentrated in the nuclei of transfected HeLa cells ([Fig. 2](#F2){ref-type="fig"}A). EGFP3 fused to Tpg^Sco^ lacking this decapeptide was localized mainly in the cytosol (pEGFP3-Tpg^Sco^ΔNLS10C). These results indicated that the EIKRPRPDLA decapeptide was necessary and sufficient for the nuclear targeting function of Tpg^Sco^.

The putative NLS motif-containing decapeptide QIKKPRPDLA in Tpg^Sav^, which differs from that in Tpg^Sco^ by two aa residues ([Fig. 1](#F1){ref-type="fig"}A), could also target EGFP3 into the nuclei (pEGFP3-NLS10A; [Fig. 2](#F2){ref-type="fig"}A). Moreover, a putative NLS motif-containing decapeptide, KLKRPRQDLR, in Tpg^pSLA2-M^ and Tpg^pSLA2-L^ of *S. rochei* ([@B3],[@B17]), which differs from that in Tpg^Sco^ by four aa residues ([Fig. 1](#F1){ref-type="fig"}A), was also competent for nuclear localization (pEGFP3-NLS10R, [Fig. 2](#F2){ref-type="fig"}A). These results suggested that the predicted NLS sequences in all of the Tpgs (except perhaps that of pSCL2) might be functional.

The 'alanine scanning' mutation procedure ([@B18]) was employed to test the functionality of the decapeptide EIKRPRPDLA of Tpg^Sco^. Changes of the first two aa of the decapeptide to A (E1A and I2A mutations) did not affect the nuclear localization function ([Fig. 2](#F2){ref-type="fig"}B). Alteration of the third (K3A), fourth (R4A) or sixth (R6A) aa to A blocked nuclear localization. This result confirmed the essential role of key basic aa in the NLS.

The bipartite NLS in Tpc is also functional
-------------------------------------------

Tpc, the TP of the SCP1 plasmid of *S. coelicolor*, is distinct from Tpgs in both sequence and size ([@B10]). Its central region contains a predicted bipartite NLS motif of a common \[RK\]{3,}?x{8,16}\[RK\]{4,}? pattern found in nearly 200 nuclear proteins ([@B9]). Tpc-EGFP3 fusion protein (pEGFP3-Tpc) was concentrated in the nuclei of transfected HeLa cells, indicating that Tpc was also capable of nuclear targeting ([Fig. 3](#F3){ref-type="fig"}). A 27-aa polypeptide spanning the predicted NLS motif of Tpc (pEGFP3-NLS27S) was sufficient for targeting the fused EGFP3 to the nuclei of HeLa cells. This 27-aa polypeptide contains two separate putative basic aa clusters---ARVRRR and RRRKKWT. Deletion of this polypeptide from Tpc on pEGFP3-TpcΔ(NLS27S) blocked nuclear localization. Deletion of either of the basic clusters on pEGFP3-TpcΔ(ARVRRR) and pEGFP3-TpcΔ(RRRKKWT) also blocked nuclear localization ([Fig. 3](#F3){ref-type="fig"}), confirming the bipartite nature of this NLS. Figure 3.Bipartite NLS in Tpc. The sequences fused in-frame to EGFP3 are listed at the left. The two NLS clusters are underlined. The plasmid constructs are listed to the right. The nuclear localization results ('−', negative; '+', positive) are shown in the fluorescent microscopic images of a representative transfected cell.

NLS-defective TP is functional in replicating linear plasmids
-------------------------------------------------------------

While the NLS motifs in the TPs function in nuclear localization, are they also important for replication of the linear replicons? To answer this question, linear plasmids were constructed following the procedure of Qin and Cohen ([@B16]). First, an *E. coli* plasmid pLUS986 was constructed that contained the *tap^Sco^-tpg^Sco^* operon and an autonomously replicating sequence (ARS) from linear plasmid pSLA2 ([@B19]) flanked by a pair of *S. lividans* chromosomal telomeres. Such replication-proficient sequences containing telomeres, when linearized at the bracketing adventitious DNA and introduced by transformation into *Streptomyces*, can generate functional linear plasmids ([@B16],[@B20]). The Δ(*tap^Sli^*-*tpg^Sli^*) mutant MR04 of *S. lividans* ([@B14]) transformed with pLUS986 DNA that had been linearized by *Ase*I digestion (at the *E. coli* vector sequence) harbored an11.7 kb linear plasmid (designated pLUS986L) with the expected size and the expected *Sac*I restriction fragments ([Fig. 4](#F4){ref-type="fig"}A). In this assay, linear plasmids that do not encode a functional TP and necessary accessory protein(s) cannot replicate in MR04, and only circular form may be found in transformants. Circular pLUS986 DNA possessing a single *Sac*I site would produce only a single (linear) *Sac*I fragment on digestion. Next, the K3A and R4A mutations in NLS (above) were each introduced into the *tpg^Sco^* gene on pLUS986 to give rise to plasmids pLUS986(K3A) and pLUS986(R4A), respectively. Transformation of MR04 with these plasmids linearized by *Ase*I also produced linear plasmids \[designated pLUS986(K3A)L and pLUS986(R4A)L, respectively\] with the expected size and *Sac*I fragments ([Fig. 4](#F4){ref-type="fig"}B). These results indicate that a functional NLS in Tpg^Sco^ is not necessary for performing the end patching role. Figure 4.NLS-defective TPs are functional in replication. (**A**) Mini linear plasmids constructed. pLUS986L contains a pair of *S. lividans* telomeres (filled arrows) capped by the Tpg^Sco^ proteins (filled circles) encoded by the *tpg^Sco^* it carries. pLUS986(K3A)L and pLUS986(R4A)L are pLUS986L containing the K3A and R4A mutation in the NLS of Tpg^Sco^ ([Fig. 2](#F2){ref-type="fig"}B), respectively. pLUS892 contains a pair of SCP1 telomeres (terminal open arrows) capped by Tpc proteins (open circles) encoded by the *tpc* it carries ([@B10]). pLUS892(ΔARVRRR)L is a derivative of pLUS892L containing the Δ(ARVRRR) mutation in the NLS of Tpc ([Fig. 3](#F3){ref-type="fig"}). The *Sac*I (Sc) restriction site and the size of the expected restriction fragments are indicated. ARS, autonomously-replicating sequence of pSLA2. (**B**) NLS-defective TPs cap mini linear plasmids. *S. lividans* strains (see text) were transformed by the circular progenitor of the five mini linear plasmids, pLUS986, pLUS986(K3A), pLUS986(R4A), pLUS892, and pLUS892(ΔARVRRR) that had been digested by *AseI*. Thiostrepton-resistant transformants were isolated, and DNA extracted from the transformants, digested by *Sac*I ('+', with digestion; '−\'without digestion), and electrophoresed. The number and size of the *Sac*I fragments of the plasmids were as expected from the linear plasmids. Circular plasmids would give only a single *Sac*I fragment.

Using the same procedure, the Δ(ARVRRR) mutation was introduced into the *tpc* gene on a mini linear plasmid, pLUS892L ([@B10]), which contained the essential *tac* and *tpc* gene pair, the pSLA2 ARS, and a pair of SCP1 telomeres. The resulting plasmid, pLUS892(ΔARVRRR)L, capped by the NLS-defective Tpc also replicated as a linear DNA in TK64 ([Fig. 4](#F4){ref-type="fig"}B). These results indicated that a functional NLS in Tpc was also not essential for end patching.

The finding that two different classes of *Streptomyces* TPs contains different types of NLS motifs, which are functional in nuclear targeting but not required for replication, indicates that the nuclear localization functions have not emerged coincidentally, but have evolved convergently in two different systems for an identical biological role.

TPs carried covalently bound DNA into the nuclei
------------------------------------------------

To determine whether TP may lead covalently linked DNA into the nuclei a linear plasmid, pLUS966-EGFP3L, was constructed that contained a pair of *S. lividans* telomeres and the EGFP3 gene under the control of the CMV promoter ([Fig. 5](#F5){ref-type="fig"}A and B). In cells transfected with the Tpg^Sco^-capped pLUS966-EGFP3L DNA, transient expression of EGFP3 was observed after 6 h in HeLa ([Fig. 5](#F5){ref-type="fig"}C) and HEK 293T cells and reached a maximum of ∼70% ([Fig. 5](#F5){ref-type="fig"}D). In comparison, in transfection by the progenitor circular plasmid pLUS966-EGFP3 and proteinase K-treated pLUS966-EGFP3L DNA, fluorescent cells were seen after 12 h and reached a lower maximum (∼60%). Figure 5.Delivery of TP-capped DNA into the nuclei. (**A**) pLUS966-EGFP3 containing a linear plasmid sequence with an EGFP3 gene under the control of the CMV promoter. The promoters and genes are indicated by the open arrows, and the *S. lividans* telomeres by filled arrows. *tsr*, thiostrepton resistance gene; *rep1* and *rep2*, replication genes of pSLA2 ([@B19]); *neo-r*, neomycin resistance gene. (**B**) Linear plasmid pLUS966-EGFP3-L capped by Tpg^Sco^ (filled circles) obtained by transformation of *S. lividans* by *Ase*I-linearized pLUS966-EGFP3 DNA. (**C**) Transfer and expression of EGFP3 in transfected cells. After transfection, fluorescent cells were photographed and counted under fluorescence microscope. Representative bright-field and fluorescence photographs of transfected HeLa cells at 6 and 14 h after transfection are shown. 1, pLUS966-EGFP3L DNA; 2, pLUS986(K3A)-EGFP3L DNA; 3, proteinase K-treated pLUS966-EGFP3L DNA; 4, pLUS966-EGFP3 DNA. (**D**) Comparison of efficiency of EGFP3 transfer and expression. Upper panel, HeLa cells; lower panel, HEK 293T cells. Fluorescent cells were counted after transfection. Filled circles, pLUS966-EGFP3L DNA; open circles, pLUS986(K3A)-EGFP3L DNA; open triangles, proteinase K-treated pLUS966-EGFP3L DNA; filled triangles, pLUS966-EGFP3 DNA.

The high efficiency of gene delivery by the Tpg^Sco^-capped linear DNA might be due to either active nuclear targeting conferred by the TP or protection against cellular exonuclease attack. To resolve this issue, EGFP3 was placed on pLUS986(K3A)L, which was capped by an NLS-defective (K3A) Tpg^Sco^. Transfection using the resultant plasmid produced similar results as the circular DNA and uncapped linear DNA in both HeLa and HEK 293T cells, i.e. later appearance and lower numbers of fluorescent transformants than the linear DNA capped by normal Tpg^Sco^ ([Fig. 5](#F5){ref-type="fig"}D). This result indicated the higher efficiency of delivery by Tpg^Sco^ was mainly conferred by the active nuclear targeting function of its NLS.

DISCUSSION
==========

New NLS motifs in Tpgs
----------------------

We have demonstrated that the predicted monopartite NLS in Tpg^Sco^, Tpg^Sli^, Tpg^Sav^ and Tpg^pSLA2-L^/Tpg^pSLA2-M^ were functional in nuclear targeting either as separate domains or as part of the Tpg proteins. The predicted bipartite NLS motif on Tpc, which is found in nearly 200 nuclear proteins, is also functional in nuclear targeting, and the basic residues in both of its two clusters are essential for function.

The laboratory-observed nuclear targeting function of the NLSs in Tpgs and Tpc, which is not essential for the end-patching function, strongly suggests a role in nature. However, there is no nucleus in bacteria, hence what would be the biological function of these NLSs?

Nuclear transport of proteins bearing an NLS is mediated by the importin α/β heterodimer in eukaryotes. It is possible that Tpgs and Tpc interact with a similar system and perform an unknown biological process in *Streptomyces*. To investigate this possibility, we used the importins α and β sequences from human, mouse, *Drosophila melanogaster* and *Arabidopsis thaliana* as query in blastp and psi-blast searches against the *S. coelicolor* and *S. avermitilis* genomic databases. No significant homologous hit (*E*-values \< 0.1) was found. Therefore, either the NLS motifs in Tpgs and Tpc interact with a heterologous system in *Streptomyces*, or they interact with a system outside of *Streptomyces*.

TP-mediated transfer is similar to T-DNA transfer
-------------------------------------------------

TP-mediated DNA transfer is analogous to the transfer of T-DNA by *Agrobacterium tumefaciens*. During conjugation with a plant cell, a Ti plasmid-encoded VirD2 protein in *A. tumefaciens* nicks at a border of the T-DNA sequence and remains covalently bound to the 5′ end. A rolling circle-type replication initiated at the nick, followed by a second nick, removes a single-strand stretch of T-DNA, which is transported into the plant cell. Inside the plant cells, the T-DNA is bundled by another T-DNA-encoded protein, VirE2, and led by the VirD2 protein into the plant nuclei, where integration takes place. VirD2 contains a monopartite and a bipartite NLS, which are required for nuclear targeting ([@B21]). VirD2 is attached to the T-DNA at a Tyr residue ([@B22]), whereas Tpg^Sco^ is attached to the *Streptomyces* DNA at a Thr residue ([@B6]).

Both being soil bacteria, agrobacteria and streptomycetes may have more genetic interactions than have been noted. First, Kelly and Kado ([@B23]) recently reported that T-DNA may be transferred and integrated by *Agrobacterium* into the chromosome of *Streptomyces*. Second, the linear plasmid SLP2 of *S. lividans* contains a pair of homologs of two hypothetical genes, *ymg* and *yme*, which are present on an octopine-type Ti plasmid of *A. tumefaciens* in an identical arrangement ([@B24]). Codon usage analysis suggests that these two genes were horizontally acquired, perhaps through gene exchanges between a linear plasmid of *Streptomyces* and the Ti-plasmid of *A. tumefaciens*.

We propose that TP-capped linear DNA of *Streptomyces*, like the Ti plasmids of *A. tumefaciens*, is also involved in inter-kingdom gene transfer in soil. The target of such proposed transfer is not clear. *Streptomyces* species are highly abundant in soil, and the likely eukaryotic targets for transfer include plants and fungi. Such transfer, if real, would be of great evolutionary and ecological significance.

The existence of many genes of bacterial origin in the genomes of plants and other eukaryotes ([@B25]) has been suggested to result from horizontal gene transfer mediated by bacterial systems such as the Ti-plasmids ([@B26]). The TP-capped linear DNA system may also be involved in such inter-kingdom gene transfer.

The *Streptomyces* TP as a gene delivery tool
---------------------------------------------

The Ti-plasmids of *Agrobacterium* are the most effective gene delivery tool in plant biotechnology (review in [@B27]). They have also been adopted for gene transfer for other targets such as human nuclei ([@B28]) and mammalian mitochondria ([@B29]). In addition, NLSs have been used in various systems to aid non-viral gene delivery in human gene therapy (reviewed by [@B30; @B31; @B32]). In these schemes, the positively charged NLSs are coupled with the negatively charged DNA, or covalently coupled with a carrier component/condensing agent or the phosphate--sugar backbone of the DNA.

The disadvantage of non-covalent coupling of NLS-containing peptides is that dissociation of the complex can occur during intracellular trafficking. The non-specific covalent coupling of NLS peptides to plasmid DNA does not markedly enhance nuclear uptake or increase reporter gene expression, while the covalent attachment of NLS peptides may inhibit intended gene expression. To prevent such inhibition, NLS peptides are coupled with specific locations in the plasmid DNA---primarily at the termini. Zanta *et al*. ([@B33]) reported a 10- to 1000-fold increase (depending on the cell types used) in gene expression using a linear DNA construct with a SV40-derived NLS peptide coupled with one of the hairpin ends compared with the DNA construct without the NLS peptide cap. However, similar attempts (for example, [@B34],[@B35]) met with little or no success.

In comparison to the existing NLS-aided gene delivery systems, the TP-capped *Streptomyces* replicons offer an efficient alternative. The TP caps offer both an active nuclear localization function and protection from cellular exonucleases, which is one of the gene delivery barriers ([@B36]). TP capping is biological and complete, and does not require elaborate physical and chemical procedures. Only standard molecular cloning techniques in *E. coli* and *Streptomyces* are required for production of TP-capped linear DNA for transfection. The size of inserts is limited by that of the cloning systems. *E. coli* plasmid vectors generally can accommodate inserts of tens of kb, and linear *Streptomyces* plasmids reach 1 Mb. Such a promising gene delivery system requires vigorous study and development. Notably, while this article was being prepared, the idea of using TP-capped linear DNA as 'a potential new strategy for assembly of synthetic therapeutic gene vector' was proposed by Tolmachov and Coutelle ([@B37]).
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